Literature DB >> 10801890

Identification and functional expression of four isoforms of ATPase II, the putative aminophospholipid translocase. Effect of isoform variation on the ATPase activity and phospholipid specificity.

J Ding1, Z Wu, B P Crider, Y Ma, X Li, C Slaughter, L Gong, X S Xie.   

Abstract

ATPase II, a vanadate-sensitive and phosphatidylserine-dependent Mg(2+)-ATPase, is a member of a subfamily of P-type ATPase and is presumably responsible for aminophospholipid translocation activity in eukaryotic cells. The aminophospholipid translocation activity plays an important physiological role in the maintenance of membrane phospholipid asymmetry that is observed in the plasma membrane as well as the membranes of certain cellular organelles. While the preparations of ATPase II from different sources share common fundamental properties, such as substrate specificity, inhibitor spectrum, and phospholipid dependence, they are divergent in several characteristics. These include specific ATPase activity and phospholipid selectivity. We report here the identification of four isoforms of ATPase II in bovine brain. These isoforms are formed by a combination of two major variations in their primary sequences and show that the structural variation of these isoforms has functional significance in both ATPase activity and phosholipid selectivity. Furthermore, studies with the phosphoenzyme intermediate of ATPase II and its recombinant isoforms revealed that phosphatidylserine is essential for the dephosphorylation of the intermediate. Without phosphatidylserine, ATPase II would be accumulated as phosphoenzyme in the presence of ATP, resulting in the interruption of its catalytic cycle.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801890     DOI: 10.1074/jbc.M910319199

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  41 in total

Review 1.  Phagocyte receptors for apoptotic cells: recognition, uptake, and consequences.

Authors:  V A Fadok; D L Bratton; P M Henson
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

2.  Identification of residues defining phospholipid flippase substrate specificity of type IV P-type ATPases.

Authors:  Ryan D Baldridge; Todd R Graham
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

3.  Atp8a1 deficiency is associated with phosphatidylserine externalization in hippocampus and delayed hippocampus-dependent learning.

Authors:  Kelly Levano; Vineet Punia; Michael Raghunath; Priya Ranjan Debata; Gina Marie Curcio; Amit Mogha; Sudarshana Purkayastha; Dan McCloskey; Jimmie Fata; Probal Banerjee
Journal:  J Neurochem       Date:  2011-12-02       Impact factor: 5.372

4.  Outside of the box: recent news about phospholipid translocation by P4 ATPases.

Authors:  Alex Stone; Patrick Williamson
Journal:  J Chem Biol       Date:  2012-07-15

5.  Auto-inhibition of Drs2p, a yeast phospholipid flippase, by its carboxyl-terminal tail.

Authors:  Xiaoming Zhou; Tessy T Sebastian; Todd R Graham
Journal:  J Biol Chem       Date:  2013-09-17       Impact factor: 5.157

Review 6.  Decoding P4-ATPase substrate interactions.

Authors:  Bartholomew P Roland; Todd R Graham
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-10-04       Impact factor: 8.250

Review 7.  Lipid somersaults: Uncovering the mechanisms of protein-mediated lipid flipping.

Authors:  Thomas Günther Pomorski; Anant K Menon
Journal:  Prog Lipid Res       Date:  2016-08-12       Impact factor: 16.195

8.  Drs2p-coupled aminophospholipid translocase activity in yeast Golgi membranes and relationship to in vivo function.

Authors:  Paramasivam Natarajan; Jiyi Wang; Zhaolin Hua; Todd R Graham
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

Review 9.  Linking phospholipid flippases to vesicle-mediated protein transport.

Authors:  Baby-Periyanayaki Muthusamy; Paramasivam Natarajan; Xiaoming Zhou; Todd R Graham
Journal:  Biochim Biophys Acta       Date:  2009-03-12

10.  A genetic strategy involving a glycosyltransferase promoter and a lipid translocating enzyme to eliminate cancer cells.

Authors:  Kelly Levano; Tomasz Sobocki; Farah Jayman; Priya Ranjan Debata; Malgorzata B Sobocka; Probal Banerjee
Journal:  Glycoconj J       Date:  2009-03-12       Impact factor: 2.916

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.